(S (NP (NP (DT The) (NNS improvements)) (PP (IN in) (NP (NML (JJ magnetic) (NN resonance)) (NN imaging)))) (VP (VBP have) (VP (VBN led) (PP (IN to) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (JJ numerous) (NNS techniques))))) (S (VP (TO to) (ADVP (RBR better)) (VP (VB detect) (NP (NP (JJ structural) (NNS alterations)) (VP (VBN caused) (PP (IN by) (NP (JJ neurodegenerative) (NNS diseases)))))))))) (. .))
(S (PP (IN Among) (NP (DT these))) (, ,) (NP (ADJP (NP (DT the) (NN patch)) (HYPH -) (VBN based)) (NN grading) (NN framework)) (VP (VBZ has) (VP (VBN been) (VP (VBN proposed) (PP (IN to) (NP (NP (NN model) (JJ local) (NNS patterns)) (PP (IN of) (NP (JJ anatomical) (NNS changes)))))))) (. .))
(S (NP (DT This) (NN approach)) (VP (VBZ is) (ADJP (JJ attractive) (PP (IN because) (PP (IN of) (NP (NP (PRP$ its) (JJ low) (JJ computational) (NN cost)) (CC and) (NP (PRP$ its) (JJ competitive) (NN performance))))))) (. .))
(S (NP (JJ Other) (NNS studies)) (VP (VBP have) (VP (VBN proposed) (S (VP (TO to) (VP (VB analyze) (NP (NP (DT the) (NNS deformations)) (PP (IN of) (NP (NN brain) (NNS structures)))) (S (VP (VBG using) (NP (NP (ADJP (NP (NN tensor)) (HYPH -) (VBN based)) (NN morphometry)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (NP (DT a) (ADJP (RB highly) (JJ interpretable)) (NN approach))))))))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN work))) (, ,) (NP (PRP we)) (VP (VBP propose) (S (VP (TO to) (VP (VB combine) (NP (NP (DT the) (NNS advantages)) (PP (IN of) (NP (DT these) (CD two) (NNS approaches)))) (PP (IN by) (S (VP (VBG extending) (NP (NP (ADJP (NP (DT the) (NN patch)) (HYPH -) (VBN based)) (NN grading) (ADJP (NP (NP (NN framework)) (PP (IN with) (NP (DT a) (JJ new) (NN tensor)))) (HYPH -) (VBN based)) (NN grading) (NN method)) (SBAR (WHNP (WDT that)) (S (VP (VBZ enables) (S (NP (PRP us)) (VP (TO to) (VP (VB model) (NP (NP (NNS patterns)) (PP (IN of) (NP (JJ local) (NN deformation)))) (S (VP (VBG using) (NP (DT a) (ADJP (NN log) (HYPH -) (JJ Euclidean)) (JJ metric)))))))))))))))))) (. .))
(S (NP (PRP We)) (VP (VBP evaluate) (NP (PRP$ our) (JJ new) (NN method)) (PP (IN in) (NP (NP (DT a) (NN study)) (PP (IN of) (NP (NP (DT the) (NN putamen)) (PP (IN for) (NP (NP (DT the) (NN classification)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NP (JJS pre-manifest)) (NP (NP (NNP Huntington) (POS 's)) (NN disease))) (CC and) (NP (JJ healthy) (NNS controls))))))))))))) (. .))
